Vericel (VCEL) EBITDA Margin (2009 - 2026)
Vericel's EBITDA Margin was 5.23% in Q2 2026, up 3.97 percentage points from 1.26% a year earlier and up 12.24 percentage points from the prior quarter.
Powered by 
Analysis
Vericel (VCEL) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vericel's EBITDA Margin was 10.17% through Jun 30, 2026, up 6.35 percentage points year-over-year; for FY2025, it came in at 8.18%, up 3.95 percentage points from FY2024.
- EBITDA Margin has now increased for three consecutive years, with a five-year change of +4.33 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 4.23% in FY2024 (+5.15 pp), -0.93% in FY2023 (+7.03 pp), -7.96% in FY2022 (-4.83 pp) and -3.13% in FY2021 (-6.97 pp).
- Quarterly EBITDA Margin has moved between -21.55% (Q2 2022) and 27.45% (Q4 2025) over five years.
- Compared with a year earlier, EBITDA Margin has increased for five straight quarters, with an average year-over-year change of +4.91 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q1 2026 (a gain of 12.20 percentage points); the worst was Q3 2021 (a drop of 25.02 percentage points).
- Per Business Quant data, VCEL's EBITDA Margin in the three quarters before Q2 2026 was -7.01% (Q1 2026), 27.45% (Q4 2025) and 9.47% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Vericel | 3.01 Bn | 2.40 Bn | 62.61 Mn | 18.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.58% |
| Jun 30, 2026 | 5.30% |
| Mar 31, 2026 | -6.93% |
| Dec 31, 2025 | 27.50% |
| Sep 30, 2025 | 9.55% |
| Jun 30, 2025 | 1.35% |
| Mar 31, 2025 | -19.11% |
| Dec 31, 2024 | 26.55% |
| Sep 30, 2024 | -1.88% |
| Jun 30, 2024 | -8.84% |
| Mar 31, 2024 | -7.86% |
| Dec 31, 2023 | 21.44% |
| Sep 30, 2023 | -8.45% |
| Jun 30, 2023 | -10.31% |
| Mar 31, 2023 | -16.98% |
| Dec 31, 2022 | 13.62% |
| Sep 30, 2022 | -14.92% |
| Jun 30, 2022 | -21.55% |
| Mar 31, 2022 | -17.74% |
| Dec 31, 2021 | 10.31% |
API Access
Vericel EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();